FDA inspection
Noven Pharmaceuticals, Inc.: FDA inspection ending Feb 13, 2026
FDA inspection 1285900 · No Action Indicated (NAI) · Miami, FL
Key facts
| Inspection ID | 1285900 |
|---|---|
| Firm | Noven Pharmaceuticals, Inc. |
| FEI number | 1000222037 |
| Address | 11960 Sw 144th St |
| City | Miami |
| State | FL |
| ZIP | 33186 |
| Country | United States |
| Fiscal year | 2026 |
| Inspection end date | Feb 13, 2026 |
| Classification | No Action Indicated (NAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data